| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817556 | Clinical Biochemistry | 2016 | 5 Pages |
Abstract
DPP-IV activity is a good, new and valuable biomarker distinguishing between MPS and healthy individuals. However, it is not a useful marker of treatment efficacy and is unsuitable for monitoring.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Katarzyna HetmaÅczyk, MaÅgorzata Bednarska-Makaruk, Karolina Kierus, Sylwia Murawska-Izdebska, Dorota Piekutowska-Abramczuk, Bożena Pilch, Anna Tylki-SzymaÅska, Agnieszka Åugowska,